Long-term subarachnoid haemorrhage survivors still die due to cerebrovascular causes

C Lindgren1, S Söderberg2, L-O D Koskinen3

  • 1Department of Surgical and Perioperative Sciences, Anaesthesiology and Intensive Care, Umeå University, Umeå, Sweden.

Insights

Long-term survivors of subarachnoid hemorrhage (SAH) face a significantly higher risk of death from cerebrovascular diseases. This study found no increased cardiovascular disease mortality risk in SAH survivors compared to the general population.

Area of Science:

  • Neurology
  • Cardiology
  • Public Health

Background:

  • Subarachnoid hemorrhage (SAH) is linked to sympathetic nervous system activation and inflammation.
  • These physiological responses suggest SAH may be a risk factor for cardiovascular disease development.

Purpose of the Study:

  • To investigate the long-term risk of cardiovascular death in subarachnoid hemorrhage survivors.
  • To determine if SAH survivors have an increased mortality risk due to cardiovascular causes one year or more after the event.

Main Methods:

  • Retrospective analysis of SAH patients (≥18 years) treated at Umeå University Hospital (1986-2006).
  • Identification of deceased patients via the Swedish population register and analysis of death certificates.
  • Comparison of mortality data with the general population and cardiovascular risk factors from the northern Sweden MONICA (Multinational Monitoring of Trends and Determinants in Cardiovascular Disease) survey.
  • Stratified analyses by age and sex.

Main Results:

  • Long-term SAH survivors showed a significantly increased risk of death from cerebrovascular disease compared to the general population (P < 0.0001).
  • No significant increase in death risk from cardiovascular disease was observed in SAH survivors.
  • Hypertension was more prevalent in SAH patients than in the general population (P < 0.01).

Conclusions:

  • Cerebrovascular causes of death are significantly more common in long-term survivors of subarachnoid hemorrhage.
  • While SAH is associated with hypertension, it does not appear to increase long-term cardiovascular mortality risk.
Abstract